Press Releases

February 16, 2021
Accolade to Participate in Upcoming Investor Conferences
SEATTLE, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the following upcoming investor
Additional Formats
January 27, 2021
Accolade Welcomes Cindy R. Kent to its Board of Directors
Business leader, healthcare executive and one of Savoy Magazine's 2020 leading executives is driving positive change for the healthcare experience in the U.S. SEATTLE , Jan. 27, 2021 /PRNewswire/ --   Accolade (Nasdaq: ACCD), which provides personalized, technology-enabled solutions that help
Additional Formats
January 14, 2021
Accolade to Acquire 2nd.MD
The addition of 2nd.MD’s Expert Medical Opinion services to Accolade’s portfolio of high-touch, technology-enabled health and benefits solutions expands Accolade’s clinical capabilities and creates the market’s most comprehensive, integrated healthcare navigation experience. SEATTLE, Jan.
Additional Formats
January 7, 2021
Accolade Announces Results for Fiscal Third Quarter 2021
Fiscal third quarter 2021 revenue of $38.4 million, a 30% increase compared to fiscal third quarter 2020 revenue of $29.7 million, driven primarily by strength in new customer additions across market segments and offerings  Company raises revenue outlook for fiscal year 2021 to a range of $162
Additional Formats

Search Investor Relations